Cefpodoxime proxetil is an oral antibiotic having the extended-spectrum, semi-synthetic cephalosporin group antibiotic. Cefpodoxime mainly gram-negative coverage, but also covers some gram-positive organisms.

The drug is highly stable in the presence of beta-lactamase enzymes, as a result, many organisms resistant to penicillins and some cephalosporins (due to beta-lactamases) may be susceptible to cefpodoxime. Cefpodoxime is indicated for the treatment of upper and lower respiratory tract infections, urinary tract infections, sexually transmitted diseases, and skin and skin structure infections. Cefpodoxime has a long half-life, allowing twice-daily administration.

Vantipod has 5 strengths

Vantipod 200	(Cefpodoxime Proxetil 200 mg Tablet) Packing – 10x10
Vantipod 200 CV	(Cefpodoxime 200mg + Clavulanic acid 125mg Tablet ) Packing 10x10
Vantipod 100 Dry Syrup	(Cefpodoxime 100mg / 5ml Dry Syrup along with SFI) Packing 30ml
Vantipod 50mg Dry Syrup	(Cefpodoxime 50mg/5ml Dry Syrup along with SFI) Packing 30ml
Vantipod 50 CV Dry Syrup	(Cefpodoxime 50mg+Clavulanic acid 31.25mg /5ml Dry Syrup Along with SFI) Packing 30ml